• Twenty Years of Diabetes surveillance using the Canadian Chronic Disease Surveillance System
• Summary Safety Review - SGLT2 inhibitors - Assessing the potential risk of …
• Insulin Products
• Summary Safety Review - SGLT2 Inhibitors (canagliflozin, dapagliflozin, empagliflozin) - Assessing the …
• Summary Safety Review - GARDASIL (Quadrivalent Human Papillomavirus [Types 6, 11, 16, …